Completed PHASE1 INTERVENTIONAL 2-arm NCT01268787

A Study to Evaluate the Safety and Immunogenicity of EV71 Vaccine

A Phase I, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of EV71 Vaccine Administrated With Adjuvant AlPO4 in Health Volunteers

Sponsor: National Health Research Institutes, Taiwan

Conditions Enterovirus Infection

Interventions EV71 vaccine

Updated 5 times since 2017 Last updated: Apr 15, 2015 Started: Dec 31, 2010 Primary completion: Mar 31, 2012 Completion: Sep 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Enterovirus Infection and is currently completed. National Health Research Institutes, Taiwan leads this study, which shows 5 recorded versions since 2010 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Dec 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Health Research Institutes, Taiwan

Data source: National Health Research Institutes, Taiwan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taipei, Taiwan